453 related articles for article (PubMed ID: 19109962)
1. Infliximab prevents Crohn's disease recurrence after ileal resection.
Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Crohn's disease: prevention and treatment.
El-Hachem S; Regueiro M
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):249-56. PubMed ID: 19485807
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?
Pons Beltrán V; Nos P; Bastida G; Beltrán B; Argüello L; Aguas M; Rubín A; Pertejo V; Sala T
Gastrointest Endosc; 2007 Sep; 66(3):533-40. PubMed ID: 17725942
[TBL] [Abstract][Full Text] [Related]
4. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
5. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the prevention of postoperative recurrence of Crohn's disease.
Yamamoto T; Watanabe T
Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
[TBL] [Abstract][Full Text] [Related]
7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
8. Preventive therapy in postoperative Crohn's disease.
Swoger JM; Regueiro M
Curr Opin Gastroenterol; 2010 Jul; 26(4):337-43. PubMed ID: 20571386
[TBL] [Abstract][Full Text] [Related]
9. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
[TBL] [Abstract][Full Text] [Related]
10. [Biological treatment of refractory Crohn's disease: three years of observation].
Lazebnik LB; Kniazev OV; Parfenov AI; Konopliannikov AG; Sagynbaeva VE; Ruchkina IN; Gudkova RB; Khomeriki SG; Chikunova BZ; Mikhaĭlova ZF; Shcherbakov PL; Rogozina VA
Eksp Klin Gastroenterol; 2011; (3):42-53. PubMed ID: 21695952
[No Abstract] [Full Text] [Related]
11. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.
Ewe K; Böttger T; Buhr HJ; Ecker KW; Otto HF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):277-82. PubMed ID: 10333200
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series.
Savarino E; Dulbecco P; Bodini G; Assandri L; Savarino V
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):468-70. PubMed ID: 22266834
[TBL] [Abstract][Full Text] [Related]
13. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
Maser EA; Villela R; Silverberg MS; Greenberg GR
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
[TBL] [Abstract][Full Text] [Related]
14. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
[TBL] [Abstract][Full Text] [Related]
15. Short-term study of infliximab treatment for Crohn's disease in China.
Zheng JJ; Zhi P; Wang YM; Zhu F; Gu W; Xing YC; Zhou CL; Shen BW
J Dig Dis; 2011 Apr; 12(2):105-9. PubMed ID: 21401895
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Rutgeerts P
Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P
World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Crohn's disease by infliximab. About 20 cases].
Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
[TBL] [Abstract][Full Text] [Related]
19. Trends in surgery for Crohn's disease in the era of infliximab.
Jones DW; Finlayson SR
Ann Surg; 2010 Aug; 252(2):307-12. PubMed ID: 20585239
[TBL] [Abstract][Full Text] [Related]
20. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
